Table 2.
Prevalence of the most common disorders at a fine-level of diagnostic precision recorded in Boxers (n = 3,219) under primary veterinary care at UK practices participating in the VetCompass™ Programme from January 1st, 2016 to December 31st, 2016. Disorders with 40 or more events included
| Fine-level Disorder | No | Overall prevalence % | 95% CIa | Median age (years) | Female prevalence % | Male prevalence % | Sex P-value* | White prevalence | Non-white prevalence | Colour P-value** |
|---|---|---|---|---|---|---|---|---|---|---|
| Otitis externa | 230 | 7.15 | 6.31–8.09 | 5.50 | 7.00 | 7.27 | 0.772 | 7.30 | 7.35 | 0.974 |
| Epulis | 188 | 5.84 | 5.08–6.70 | 8.75 | 6.36 | 5.35 | 0.223 | 5.71 | 5.83 | 0.935 |
| Corneal ulceration | 161 | 5.00 | 4.30–5.81 | 8.77 | 4.60 | 5.35 | 0.336 | 6.03 | 5.14 | 0.503 |
| Periodontal disease | 149 | 4.63 | 3.96–5.41 | 8.66 | 5.58 | 3.72 | 0.012 | 6.98 | 4.53 | 0.054 |
| Heart murmur | 138 | 4.29 | 3.64–5.04 | 7.55 | 3.50 | 4.98 | 0.038 | 4.13 | 4.38 | 0.835 |
| Skin mass | 138 | 4.29 | 3.64–5.04 | 8.70 | 5.32 | 3.36 | 0.006 | 4.76 | 4.38 | 0.756 |
| Obesity | 123 | 3.82 | 3.21–4.54 | 6.64 | 4.09 | 3.54 | 0.423 | 3.17 | 3.81 | 0.575 |
| Overgrown nail(s) | 118 | 3.67 | 3.07–4.37 | 6.77 | 4.02 | 3.24 | 0.239 | 3.17 | 3.81 | 0.575 |
| Hypersensitivity allergy disorder | 95 | 2.95 | 2.42–3.59 | 4.71 | 3.11 | 2.82 | 0.628 | 2.86 | 3.09 | 0.824 |
| Aggression | 90 | 2.80 | 2.28–3.42 | 5.96 | 1.56 | 3.96 | < 0.001 | 2.54 | 2.93 | 0.694 |
| Diarrhoea | 85 | 2.64 | 2.14–3.25 | 2.87 | 2.33 | 2.94 | 0.284 | 2.86 | 2.67 | 0.843 |
| Osteoarthritis | 82 | 2.55 | 2.06–3.15 | 9.97 | 2.66 | 2.46 | 0.725 | 3.49 | 2.55 | 0.327 |
| Post-operative complication | 68 | 2.11 | 1.67–2.67 | 3.61 | 1.88 | 2.28 | 0.427 | 1.27 | 2.21 | 0.273 |
| Urinary incontinence | 65 | 2.02 | 1.59–2.57 | 9.91 | 3.70 | 0.48 | < 0.001 | 1.90 | 2.02 | 0.891 |
| Aural discharge | 64 | 1.99 | 1.56–2.53 | 4.14 | 1.49 | 2.46 | 0.049 | 2.54 | 2.06 | 0.573 |
| Claw injury | 63 | 1.96 | 1.53–2.50 | 4.82 | 1.95 | 1.92 | 0.961 | 1.27 | 1.98 | 0.380 |
| Mast cell tumour | 60 | 1.86 | 1.45–2.39 | 7.24 | 2.01 | 1.74 | 0.575 | 2.54 | 1.90 | 0.444 |
| Alopecia | 59 | 1.83 | 1.42–2.36 | 6.21 | 2.14 | 1.56 | 0.223 | 1.90 | 1.87 | 0.962 |
| Pyoderma | 59 | 1.83 | 1.42–2.36 | 5.27 | 1.75 | 1.92 | 0.719 | 2.86 | 1.79 | 0.191 |
| Lameness | 57 | 1.77 | 1.37–2.29 | 5.87 | 1.56 | 1.98 | 0.362 | 2.54 | 1.71 | 0.298 |
| Hypothyroidism | 54 | 1.68 | 1.29–2.18 | 8.84 | 1.56 | 1.80 | 0.589 | 0.63 | 1.83 | 0.122 |
| Thin | 53 | 1.65 | 1.26–2.15 | 2.70 | 1.62 | 1.68 | 0.893 | 2.86 | 1.52 | 0.081 |
| Conjunctivitis | 52 | 1.62 | 1.23–2.11 | 4.98 | 1.56 | 1.68 | 0.779 | 2.22 | 1.60 | 0.415 |
| Skin disorder | 50 | 1.55 | 1.18–2.04 | 5.47 | 1.75 | 1.38 | 0.399 | 1.59 | 1.64 | 0.946 |
| Limb mass | 49 | 1.52 | 1.15–2.01 | 8.14 | 1.49 | 1.56 | 0.872 | 1.27 | 1.64 | 0.622 |
| Death—unknown cause | 47 | 1.46 | 1.10–1.94 | 10.75 | 1.49 | 1.38 | 0.793 | 2.54 | 1.26 | 0.067 |
| Infectious canine tracheobronchitis | 47 | 1.46 | 1.10–1.94 | 4.35 | 1.17 | 1.74 | 0.176 | 0.95 | 1.45 | 0.479 |
| Seizure disorder | 47 | 1.46 | 1.10–1.94 | 9.59 | 1.43 | 1.50 | 0.860 | 2.22 | 1.41 | 0.262 |
| Vomiting | 47 | 1.46 | 1.10–1.94 | 4.34 | 1.49 | 1.44 | 0.906 | 2.22 | 1.49 | 0.320 |
| Anal sac impaction | 46 | 1.43 | 1.07–1.90 | 5.51 | 1.10 | 1.74 | 0.128 | 0.95 | 1.60 | 0.376 |
| Cruciate disease | 43 | 1.34 | 0.99–1.79 | 6.15 | 0.97 | 1.68 | 0.081 | 0.95 | 1.41 | 0.508 |
| Atopic dermatitis | 42 | 1.30 | 0.97–1.76 | 5.01 | 1.49 | 1.14 | 0.383 | 2.22 | 1.26 | 0.162 |
| Acrochordon | 41 | 1.27 | 0.94–1.72 | 7.42 | 1.04 | 1.04 | 0.303 | 1.59 | 1.26 | 0.624 |
| Stiffness | 41 | 1.27 | 0.94–1.72 | 10.40 | 1.23 | 1.32 | 0.822 | 1.27 | 1.22 | 0.938 |
aCI confidence interval. *The P-value reflects prevalence comparison between females and males. **The P-value reflects prevalence comparison between white and non-white Boxers